✦ LIBER ✦

A Phase 1–2 Dose-Escalating Study Evaluating the Safety and Tolerability of Istaroxime and Specific Effects on Electrocardiographic and Hemodynamic Parameters in Patients with Chronic Heart Failure with Reduced Systolic Function

✍ Scribed by Jalal K. Ghali; William B. Smith; Guillermo Torre-Amione; William Haynos; Barry K. Rayburn; Antonino Amato; Dan Zhang; Doug Cowart; Giovanni Valentini; Paolo Carminati; Mihai Gheorghiade

Book ID: 113443472
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 963 KB
Volume: 99
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2006.09.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long Term Outcomes of a Phase 1/2, Multi

Long Term Outcomes of a Phase 1/2, Multicenter, Open-Label, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Efficacy of BMN 110 in Patients with Mucopolysaccharidosis IVA (Morquio A Syndrome)

✍ Christian Hendriksz; Ashok Vellodi; Simon Jones; Hiwot Takkele; S. Lee; Sarah Ch 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Rationale and Design for a Phase II Stud

Rationale and Design for a Phase II Study Evaluating the Effect of the Cardiac Myosin Activator, CK-1827452, on Cardiac Function, Hemodynamics, and Myocardial Oxygen Consumption in Patients with Heart Failure

✍ J.D. Parker; A.D. Michaels; D.A. Kass; A.A. Wolff; G.M. Felker; F.I. Malik 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Effect of the Adenosine A1 Receptor Anta

Effect of the Adenosine A1 Receptor Antagonist, KW-3902, on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure Refractory to Maximum Doses of Conventional Diuretics: A Randomized, Double-Blind, Placebo Controlled, Dose Escalation Study

✍ Michael M. Givertz; Michael Tansey; Leeanne L. Pearson; Tara K. Fields; Howard C 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 189 KB